PHASE I, OPEN-LABEL, DRUG INTERACTION STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF KETOCONAZOLE ON SINGLE DOSE MIRABEGRON (YM178) ORAL CONTROLLED ABSORPTION SYSTEM (OCAS) IN HEALTHY ADULT SUBJECTS

被引：0
|
作者：
Sawamoto, T. [1 ]
Lee, J. [1 ]
Alak, A. [1 ]
Meijer, J. [2 ]
Roy, M. [1 ]
Zha, J. [1 ]
van Gelderen, M. [2 ]
Marion, A. [3 ]
Keirns, J. [1 ]
机构：
[1] Astellas Global Res Dev, Deerfield, IL USA
[2] Astellas Global Res Dev, Leiderdorp, Netherlands
[3] MDS Pharma Serv US Inc, Omaha, NE USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2011年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [41] Phase 1, randomized, open-label, single-dose, crossover study to evaluate the bio-equivalence of four formulations of oral rivoceranib tablets in healthy subjects.
    Weyer, Janelle
    Meng, Xianzhang
    Finis, Lynda
    Strickland, Bill
    Park, CheolHee
    Jang, Seong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects
    Gustavson, LE
    Schweitzer, SM
    Burt, DA
    Achari, R
    Rieser, MJ
    Edeki, T
    Chira, T
    Yannicelli, HD
    Kelly, MT
    CLINICAL THERAPEUTICS, 2006, 28 (03) : 373 - 387
  • [43] A Phase I Open-Label Study to Investigate the Potential Drug-Drug Interaction Between Single-Dose Dacomitinib and Steady- State Paroxetine in Healthy Volunteers
    Ruiz-Garcia, Ana
    Giri, Nagdeep
    LaBadie, Robert R.
    Ni, Grace
    Boutros, Tanya
    Richie, Nicole
    Kocinsky, Hetal S.
    Checchio, Tina M.
    Bello, Carlo L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 555 - 562
  • [44] Open-label, single-dose, phase I study evaluating the mass balance and pharmacolkinetics (PKs) of sunitinib (SU) in healthy male subjects
    Sherman, L.
    Peng, G.
    Patyna, S.
    Pool, W.
    Smeraglia, J.
    Bello, C. L.
    Garrett, M.
    Klamerus, K.
    EJC SUPPLEMENTS, 2007, 5 (04): : 116 - 116
  • [45] PHARMACOKINETIC DRUG INTERACTION STUDY BETWEEN ESLICARBAZEPINE ACETATE 1200 MG AND PHENYTOIN 300 MG: A PHASE I, OPEN-LABEL, MULTIPLE DOSE ADMINISTRATION STUDY IN HEALTHY VOLUNTEERS
    Falcao, A.
    Rocha, J. F.
    Pinto, R.
    Nunes, T.
    Soares-da-Silva, P.
    EPILEPSIA, 2013, 54 : 166 - 166
  • [46] A phase I, single-center, open-label study to investigate the absorption, distribution, metabolism and excretion of encorafenib following a single oral dose of 100 mg [14C] encorafenib in healthy male subjects
    Wollenberg, Lance
    Hahn, Erik
    Williams, Jason
    Litwiler, Kevin
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2023, 11 (05):
  • [47] Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans
    Ma, Sheng
    Yi, Ling
    Bian, Yicong
    Lv, Binhua
    Zhang, Cong
    Li, Chengwei
    Zhang, Hua
    Miao, Liyan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [48] Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects
    Luckey, Alison
    Alirol, Emilie
    Delhomme, Sophie
    O'Donnell, John
    Bettiol, Esther
    Mueller, John
    O'Brien, Seamus
    Gillon, Jean-Yves
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (05): : 770 - 780
  • [49] A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects
    Acharya, Milin
    Gonzalez, Martha
    Mannens, Geert
    De Vries, Ronald
    Lopez, Christian
    Griffin, Thomas
    NamPhuong Tran
    XENOBIOTICA, 2013, 43 (04) : 379 - 389
  • [50] PHASE I, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE STUDY TO ASSESS SAFETY AND PHARMACOKINETICS OF SUBCUTANEOUS ROZIBAFUSP ALFA IN HEALTHY JAPANESE SUBJECTS.
    Abuqayyas, L.
    Cheng, L.
    Simiens, M.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S53 - S53
12345